Final Biomarker and Efficacy Analyses of Lorlatinib in Patients With ALK-Positive Advanced NSCLC in a Phase 2 Study

Journal of Thoracic Oncology · Elsevier

Аннотация

Publication date: Available online 17 September 2026 Source: Journal of Thoracic Oncology Author(s): Todd M. Bauer, Jean-François Martini, Benjamin Besse, Chia-Chi Lin, Ross A. Soo, Gregory J. Riely, I-Ming Wang, Francesca Toffalorio, Deborah A. Shepard, Tiziana Usari, Phineas Hamilton, D. Ross Camidge, Steven Kao, Rita Chiari, Shirish Gadgeel, Enriqueta Felip, Alice T. Shaw, Benjamin J. Solomon

Читать у издателя →

Похожие статьи